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剂参与对炎症调节的作用机制，为阐明 PPAR-α在 AS 中作用提供理论依据。 
方法：本论文主要采用体外培养的 THP-1 细胞，应用实时定量逆转录聚合酶链
式反应(Real-time PCR)和酶联免疫吸附检测(ELISA)测定 OEA 对 LPS 诱导的
THP-1 细胞中 TNF-α、IL-1β、IL-6 mRNA 和蛋白的表达的影响，同时检测了
PPAR-α 及 Toll 样受体 4(TLR4)在 mRNA 和蛋白水平的表达。为了研究 OEA 的
抑制炎症作用机理，给与 TLR4 功能性抗体阻断 TLR4 或采用 siRNA 的方法干扰
PPAR-α在 THP-1 细胞中的表达后观察 OEA 的抗炎效应的变化。 结果：实验结
果表明 OEA 对 TNF-α、IL-1β、IL-6 mRNA 和蛋白的表达有抑制作用，并呈现出
一定的剂量依赖性。且 OEA 在上调 PPAR-α表达的同时能够抑制 TLR4 的表达。
加入 TLR4 阻断剂，LPS 诱导的 TNF-α分泌下调，给与 OEA 后抑制作用更加显
著。siRNA 干扰 PPAR-α 表达后，OEA 抑制 TNF-α 分泌及下调 TLR4 表达作用
明显减弱。结论：OEA 可以抑制 LPS 诱导的炎症反应中主要前炎症因子的表达，
其抗炎作用可能是通过激活 PPAR-α，下调TLR4的表达实现的。这可能是 PPAR-α
激动剂发挥抗血管炎症、延缓动脉粥样硬化进程作用的机制之一。 
















Background: Atherosclerosis is an inflammatory disease involved various kinds of 
vascular cells such as endothelium, macrophages, monocytes and vascular smooth 
muscle cells in the development of the pathogenesis. Recently, the therapeutic 
protocol has been changed from purely down-regulate hypolipemia to control and 
prevent the dysfunction of the immune cells. Therefore, to monitor and control the 
monocytes of peripheral blood, inhibit the over inflammatory responses of the 
monocytes become the key of atherosclerosis therapy. 
Oleoylethanolamide (OEA), a naturally occurring lipid that binds with high 
affinity to the PPAR-α, severs as an endogenous agonist of PPAR-α, which was 
reported has a endothelium protection effects by inhibit the expression of TNF-α 
induced vascular inherent moleculor-1, that may have effects on preventing and 
curing atherosclerosis. 
Objective: To investigate the effect and mechanism of OEA on the expression of 
some major proinflammatory cytokines in lipopolysaccharide (LPS) induced THP-1 
cells.  Methods: THP-1 cells were pretreated with different concentrations of 
OEA(10, 20，40 μmol/L)or Fenofibrate(100 μmol/L) for 1 h, before stimulated with 1 
μg/mL LPS for another 6h or 24h , the expression of cytokines were detected by 
RT-PCR, Real-time PCR and Cell Enzyme linked immunosorbent assay. Real-time 
PCR and western blot were performed to measure the expression of PPAR-α and Toll 
like receptor 4(TLR4) in mRNA and protein levels. To investigate the mechanism of 
the anti-inflammation of OEA, TLR4 blocker and siRNA were added to block the 
TLR4 and to knockdown PPAR-α. Results: The results showed OEA inhibited the 
expression of LPS induced TNF-α、IL-1β、IL-6 at mRNA and protein levels and 
markedly up-regulated PPAR-α, and inhibited the expression of TLR4 in the LPS 
induced THP-1 cells. TLR4 blocker could attenuate the expression of LPS stimulate 















TNF-α expression was partly abolished. Conclusion: These results indicate that OEA 
could inhibited the inflammatory of monocytes response to the stimulation of LPS, 
which may relate to the activation of PPAR-α and down-regulation the expression of 
TLR4. It suggested that PPARα ligands exert potential anti-inflammatory effects in 
modulation various inflammatory processes such as atherogenesis. 
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然后，活化的内皮可产生血管细胞黏附分子 1(VCAM-1)和细胞间黏附分子 1 










死因子 α(TNF-α)、白细胞介素 1(IL-1) 和白细胞介素 6(IL-6)等可刺激内皮细胞表
达黏附分子，如此循环反复，产生了大量的泡沫细胞并堆积形成脂纹[11,12]。 
接着，T 细胞活化促进病灶发展。激活的 T 淋巴细胞，巨噬细胞以及平滑肌
细胞(SMC)共同释放的细胞因子和生长因子(血小板源性生长因子，纤维母细胞生
长因子)促进 SMC 的增殖和迁移，中膜的 SMC 表达的基质金属蛋白酶(MMP)可

























图 1.1 动脉粥样硬化与炎症反应 
Fig 1.1 Atherosclerosis and inflammatory responses  
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1.2.1 过氧化物酶体增殖物激活受体-α简介 










人类 PPAR-α(NR1C1)基因，93.2kb，位于 22 号染色体 22q12-q13.1 位点，蛋
白由 468 个氨基酸编码[24]。小鼠的 PPAR-α 基因，位于 15E2 号染色体，蛋白同
样由 468 个氨基酸编码[17]。将人类和鼠类的 PPAR-α进行比较，得到的结果是在
核酸水平上有 85%的相似性，在蛋白水平上有 91%的相似性[25,26]。PPAR-α有着
核受体基因家族成员共有的结构[27]，由六个结构域组成(A-F)，如图 1.2 所示：N
末端的 A/B 区包括非配体依赖转录激活的功能区 AF1，每种亚型序列的同源性
很低，导致它们的生物功能的不同；C 结构域具有高度保守性，其上 70 个左右
的氨基酸序列构成了 DNA 结合区(DNA Binding Domain，DBD)，通过两个锌指
结构与目标基因上的 PPAR 反应元件(peroxisome proliferator response element，
PPRE) 结合；D 结构域又称铰链区，将 DBD 与配体结合区相连；C 末端的 E/F
区则是配体结合区(Ligand Binding Domain，LBD)，包括配体依赖转录激活的功
能区 AF2，LBD 包含 12 个 α螺旋和 4 个 β折叠形成一个大的疏水空穴，用于结
合配体，LBD 氨基酸链序列的不同使得各亚型的 PPARs 分别对不同配体产生亲
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